Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain in Primary Dysmenorrhea: a Pilot Study

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

February 28, 2026

Conditions
Primary Dysmenorrhea
Interventions
DRUG

DEH113

tablets

DRUG

Placebo

tablets

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY

NCT06555549 - Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain in Primary Dysmenorrhea: a Pilot Study | Biotech Hunter | Biotech Hunter